HealthcareServices

Global Postpartum Depression Market Set for Strong Expansion, Reaching $66.47 Billion With 33.1% CAGR by 2030

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the postpartum depression market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Postpartum Depression Market size between 2026 and 2035?

The postpartum depression market size has undergone substantial expansion in recent years. It is anticipated to grow from $16.05 billion in 2025 to $21.17 billion in 2026, at a compound annual growth rate (CAGR) of 31.9%. The historical growth of this market can be attributed to several factors, including the increasing recognition of maternal mental health disorders, limited early screening practices, prevalent underdiagnosis in postpartum care settings, a reliance on traditional counseling approaches, and the growth of hospital-based maternal care services.

The postpartum depression market size is anticipated to experience substantial growth over the upcoming years, projected to reach $66.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 33.1%. This expansion during the forecast period is propelled by factors such as the greater uptake of digital screening instruments, an increased emphasis on proactive maternal healthcare, the widening availability of tele-mental health services, rising investments in women’s mental well-being initiatives, and the deeper incorporation of mental health support into obstetric care. Key developments expected in this period encompass heightened public awareness and screening for postpartum mental health, greater acceptance of digital platforms for mental wellness, a stronger focus on prompt diagnosis and intervention, the extension of community-based assistance programs, and improved integration of mental health services within maternal care pathways.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13024&type=smp

Which Drivers Are Impacting Market Performance In The Postpartum Depression Market?

An increasing number of childbirths is anticipated to fuel the expansion of the postpartum depression market. Childbirth describes the natural process of a baby exiting the mother’s uterus, typically through the vaginal canal. This rise in births contributes to the postpartum depression market because postpartum depression (PPD) is a prevalent mental health condition affecting women post-delivery, manifesting in symptoms such as sadness, anxiety, fatigue, and challenges in maternal-infant bonding. As an illustration, a report from the Centers for Disease Control and Prevention, a US-based national public health organization, indicated that in January 2023, the United States experienced a 1% rise in recorded births, reaching a total of 3,664,292, relative to the prior year. Consequently, the increasing volume of childbirths is stimulating growth within the postpartum depression market.

What Segment Types Are Examined In The Postpartum Depression Market?

The postpartum depression market covered in this report is segmented –

1) By Types: Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive Compulsive Disorder, Postpartum Panic Disorder, Postpartum Post-Traumatic Stress Disorder, Postpartum Psychosis, Other Types

2) By Treatment: Psychotherapy, Medication, Supplements, Other Treatments

3) By Route of Administration: Oral, Parenteral, Other Route Of Administration

4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Postpartum Blues: Mild Emotional Disturbances, Short-term Mood Swings

2) By Postpartum Anxiety: Generalized Anxiety Disorder (GAD), Panic Attacks

3) By Postpartum Obsessive Compulsive Disorder: Intrusive Thoughts, Compulsive Behaviors

4) By Postpartum Panic Disorder: Sudden Panic Attacks, Physical Symptoms

5) By Postpartum Post-Traumatic Stress Disorder (PTSD): Trauma Response To Childbirth, Flashbacks And Anxiety

6) By Postpartum Psychosis: Hallucinations, Severe Mood Swings

7) By Other Types: Mixed Mood Disorders, Comorbid Conditions With Postpartum

Which Trends Are Influencing The Development Of The Postpartum Depression Market?

Major companies operating in the postpartum depression market are focusing on new product innovations, including regulatory milestones to advance the development and potential approval pathway of zuranolone for major depressive disorder and postpartum depression. A regulatory milestone denotes a crucial event in a drug or medical product’s lifecycle, signaling progress within the approval or compliance framework established by governmental authorities. For instance, in February 2023, Biogen Inc., a US-based biotechnology company, and Sage Therapeutics Inc., a US-based biopharmaceutical company, announced that the United States Food and Drug Administration (FDA) had accepted the submission of a New Drug Application (NDA) for zuranolone for the treatment of major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an investigational medication being evaluated as a 14-day, once-daily, rapid-acting oral therapy for individuals with MDD and PPD. This neuroactive steroid functions as a positive allosteric modulator of GABA-A receptors, representing a distinct mechanism of action. It is designed to work in persons with depression by quickly resetting dysregulated neural networks to help restore brain function. Zuranolone influences brain networks responsible for mood, arousal, behavior, and cognition.

Who Are The Core Companies Influencing Trends In The Postpartum Depression Market?

Major companies operating in the postpartum depression market are Pfizer Inc., Johnson & Johnson, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol Myers Squibb Co., AstraZeneca plc, GlaxoSmithKline LLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Biogen Inc., Sun Pharmaceutical Industries Ltd., Lupin Pharmaceuticals, Mallinckrodt Pharmaceuticals plc, Sage Therapeutics Inc., Otsuka Pharmaceutical Co. Ltd., Lundbeck A S, Janssen Pharmaceuticals, Aurobindo Pharma Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/postpartum-depression-global-market-report

Which Regions Are Projected To Dominate The Postpartum Depression Market In The Coming Years?

North America was the largest region in the postpartum depression market in 2025. The regions covered in the postpartum depression market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Postpartum Depression Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13024&type=smp

Browse Through More Reports Similar to the Global Postpartum Depression Market 2026, By The Business Research Company

Antidepressant Market Report 2026

https://www.thebusinessresearchcompany.com/report/antidepressant-global-market-report

Postpartum Health Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/postpartum-health-supplements-global-market-report

Major Depressive Disorder Market Report 2026

https://www.thebusinessresearchcompany.com/report/major-depressive-disorder-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795